vindesine has been researched along with Lymphoma, B-Cell, Marginal Zone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briere, J; d'Agay, MF; Diebold, J; Fillet, G; Gaulard, P; Haioun, C; Hermine, O; Lavignac, C; Lepage, E; Marolleau, JP; Reyas, F; Salles, G | 1 |
| Aguiló, J; García, F; Gómez, A; Grau, E; Ibáñez, JL; Mirabet, MD; Pastor, E; Perella, M | 1 |
| Katai, H; Kinoshita, T; Maruyama, K; Matsuno, Y; Sano, T; Sasako, M; Takenaka, T | 1 |
2 trial(s) available for vindesine and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; Life Tables; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Prednisone; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Risk; Vindesine | 1996 |
A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Prognosis; Prospective Studies; Stomach Neoplasms; Vincristine; Vindesine | 1997 |
1 other study(ies) available for vindesine and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
[Diagnosis and therapeutic management of gastric lymphomas].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gastrectomy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitomycin; Prednisone; Radioisotope Teletherapy; Remission Induction; Retrospective Studies; Spain; Stomach Neoplasms; Treatment Outcome; Vincristine; Vindesine | 1996 |